Vancouver, March 14, 2019 (GLOBE NEWSWIRE) -- NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE
SERVICES
(March 14, 2019)– NanoSphere Health Sciences Inc. (CSE: NSHS) (OTC: NSHSF) the biotechnology leader behind the
patented NanoSphere Delivery System™, is pleased to announce the Company has engaged Chaé Manufacturing to help the Company meet
increased demand for NanoSphere products in North America.
NanoSphere is experiencing high demand for our new line of hemp CBD products, and we are also developing new cosmeceutical and
anti-aging products for our distributors in the US, Canada and Mexico,” explained NanoSphere CEO Robert Sutton. “Our first order
from our partners in Mexico, for example, is for 60,000 units of our CBD transdermal formula for pain, and we are expecting that
will become a monthly shipment.”
Chaé Manufacturing (chaemanufacturing.com) is a premier manufacturing and fulfillment centre based in Colorado. It
is the first and only company in the US to be “ToxicFree®” Certified. The ToxicFree standard means Chaé does not produce
any product that contains potential carcinogenic ingredients such as parabens, preservatives and propylene glycol. NanoSphere
President and COO David Sutton says the agreement with Chaé allows NanoSphere to expand production as needed, while maintaining the
Company’s dedication to production of health products that ‘do no harm’.
“Chaé Manufacturing and their chief formulator Linda Chaé are the leaders in organic and non-toxic production of cosmeceutical
products, and at the same time their fulfillment centre is geared up to allow for massive expansion of our Evolve Formulas’ line of
products,” Sutton said.
NanoSphere has developed a revolutionary multi-patented delivery system using smart lipid nanoparticles, known as the NanoSphere
Delivery System™, that delivers cannabinoids nutraceuticals, cosmeceuticals and pharmaceutical drugs into the human body
through the skin or the mucosal membranes with greater bioactivity. . For example, NanoSphere produces an award-winning,
transdermal nano-particle gel that delivers cannabinoids through the skin to quickly relieve pain, inflammation and anxiety.
Chaé Manufacturing founder Linda Chaé says she’s excited to be involved in bringing a cutting edge solution to the
market.
“NanoSphere is a pioneer in the use of nanotechnology for human health, and the clinical research is showing a major boost in
the effectiveness of compounds like CBD and various medications when the NanoSphere Delivery System™ is used,” Chaé said. “We
think our participation will help NanoSphere’s growth, as we can provide help with research and development, scaled production,
shipping and logistics, and help in registering new products in foreign or domestic markets.”
The first product line being formulated at Chaé will be NanoSphere’s Evolve Formulas’ transdermal NanoSerum™ Hemp CBD formula,
used primarily to treat localized and systemic inflammation and pain. NanoSphere and its Mexican distributor Abba Imports are
currently going through the product registration process with national health regulator COFEPRIS, prior to shipping the first order
to Mexico.
On behalf of the Board
David Sutton, President and COO
Mobile: 720.520.4283
E-mail: dsutton@NanoSpherehealth.com
Media Contact:
Gary Symons
Mobile: 250.300.9352
E-mail: gsymons@NanoSpherehealth.com
About NanoSphere
NanoSphere Health Sciences LLC, is a biotechnology firm specializing in the creation of the NanoSphere Delivery System™, a
revolutionary platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for
the cannabis, pharmaceutical and animal health industries, and beyond. For more information on NanoSphere, please visit http://www.nanospherehealth.com.
About Evolve Formulas
Evolve Formulas is the provider of the world's first and only scientifically proven nanoparticle delivery system in cannabis.
Evolve’s pioneering product, Transdermal NanoSerum™, is a fast-acting, ultra-strength transdermal formula infused with
nano-encapsulated cannabis and cannabis extracts. For more information on Evolve Formulas, visit https://www.evolveformulas.com/. Follow us on Facebook, Instagram and Twitter.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
Forward Looking Statement Caution
This news release includes forward looking statements that are subject to assumptions, risks and uncertainties. Statements
in this news release which are not purely historical are forward looking statements, including without limitation any statements
concerning the Company's intentions, plans, estimates, expectations or beliefs regarding the future. Although the Company believes
that any forward looking statements in this news release are reasonable, there can be no assurance that any such forward looking
statements will prove to be accurate. The Company cautions readers that all forward looking statements, including without
limitation those relating to the Company's future operations and business prospects, are based on assumptions none of which can be
assured, and are subject to certain risks and uncertainties that could cause actual events or results to differ materially from
those indicated in the forward looking statements. Without limitation, these include assumptions, risks and uncertainties inherent
in completing sub-licensing arrangements in the United States, Canada and abroad, product demand, production, competition and
government regulation of the Cannabis industry, any and all of which may have an adverse effect on the Company’s expansion plans,
sales, revenues and its financial results and condition. Readers are advised to rely on their own evaluation of such risks
and uncertainties and should not place undue reliance on forward looking statements. Any forward looking statements are made as of
the date of this news release, and the Company assumes no obligation to update the forward looking statements, or to update the
reasons why actual events or results could or do differ from those projected in the forward looking statements, whether as a result
of new information, future events or otherwise.
Gary Symons Nanosphere Health Sciences 2503009352 gsymons@nanospherehealth.com